NO20025204L - Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon - Google Patents

Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon

Info

Publication number
NO20025204L
NO20025204L NO20025204A NO20025204A NO20025204L NO 20025204 L NO20025204 L NO 20025204L NO 20025204 A NO20025204 A NO 20025204A NO 20025204 A NO20025204 A NO 20025204A NO 20025204 L NO20025204 L NO 20025204L
Authority
NO
Norway
Prior art keywords
treating
compounds
methods
bacterial infection
preventing bacterial
Prior art date
Application number
NO20025204A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025204D0 (no
Inventor
R John Collier
Bret R Sellman
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of NO20025204D0 publication Critical patent/NO20025204D0/no
Publication of NO20025204L publication Critical patent/NO20025204L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20025204A 2000-05-04 2002-10-30 Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon NO20025204L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20180000P 2000-05-04 2000-05-04
PCT/US2001/014372 WO2001082788A2 (fr) 2000-05-04 2001-05-04 Traitement et prevention d'infections bacteriennes et composes a cet effet

Publications (2)

Publication Number Publication Date
NO20025204D0 NO20025204D0 (no) 2002-10-30
NO20025204L true NO20025204L (no) 2002-12-16

Family

ID=22747352

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025204A NO20025204L (no) 2000-05-04 2002-10-30 Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon

Country Status (15)

Country Link
US (1) US7037503B2 (fr)
EP (1) EP1278764A4 (fr)
JP (1) JP2003531841A (fr)
KR (1) KR20030019366A (fr)
CN (1) CN1440419A (fr)
AU (1) AU2001261171A1 (fr)
CA (1) CA2407443A1 (fr)
CZ (1) CZ20023662A3 (fr)
HU (1) HUP0301658A2 (fr)
IL (1) IL152553A0 (fr)
MX (1) MXPA02010826A (fr)
NO (1) NO20025204L (fr)
PL (1) PL365453A1 (fr)
WO (1) WO2001082788A2 (fr)
ZA (1) ZA200208835B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
AU2002239229A1 (en) * 2000-12-05 2002-06-18 Wisconsin Alumni Research Foundation Receptor for b. anthracis toxin
US7763451B2 (en) 2001-11-09 2010-07-27 The United States Of America As Represented By The Department Of Health And Human Services Methods for preparing Bacillus anthracis protective antigen for use in vaccines
RU2287581C2 (ru) * 2001-12-05 2006-11-20 Ракеш БХАТНАГАР Способ получения нетоксичной противосибиреязвенной вакцины
US20040258699A1 (en) * 2002-02-11 2004-12-23 Bowdish Katherine S. Immunotherapeutics for biodefense
EP1572903A2 (fr) * 2002-02-11 2005-09-14 Alexion Pharmaceuticals, Inc. Agents therapeutiques immunologiques destines a la biodefense
US7201912B2 (en) * 2002-04-12 2007-04-10 Emergent Biodefense Operation Lansing Inc. Recombinant immunogenic compositions and methods for protecting against lethal infections from Bacillus anthracis
WO2004003139A2 (fr) * 2002-06-26 2004-01-08 Human Genome Sciences, Inc. Sequences shine-dalgarno et procedes d'utilisation
US7601351B1 (en) 2002-06-26 2009-10-13 Human Genome Sciences, Inc. Antibodies against protective antigen
AU2003278776A1 (en) * 2002-09-10 2004-04-30 Vical Incorporated Codon-optimized polynucleotide-based vaccines against bacillus anthracis infection
WO2005004791A2 (fr) * 2002-11-08 2005-01-20 President And Fellows Of Harvard College Composes et procedes de traitement et de prevention d'infections bacteriennes
US20060014248A1 (en) * 2003-01-06 2006-01-19 Xencor, Inc. TNF super family members with altered immunogenicity
US20050130892A1 (en) * 2003-03-07 2005-06-16 Xencor, Inc. BAFF variants and methods thereof
US20050221443A1 (en) * 2003-01-06 2005-10-06 Xencor, Inc. Tumor necrosis factor super family agonists
US7553930B2 (en) * 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
US7833775B2 (en) * 2003-02-06 2010-11-16 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
US7691393B2 (en) * 2003-02-06 2010-04-06 Anza Therapeutics, Inc. Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof
US7695725B2 (en) * 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
US7842289B2 (en) * 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
US20080206276A1 (en) * 2005-07-08 2008-08-28 Michael Otto Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
CA2651962A1 (fr) * 2006-05-12 2007-12-21 Oklahoma Medical Research Foundation Compositions contre l'anthrax et procedes d'utilisation et de production de celles-ci
WO2009126355A2 (fr) * 2008-01-28 2009-10-15 Baxter International, Inc. Procédés d’augmentation de la production recombinante de l’antigène protecteur de bacillus anthracis
US20110110968A1 (en) * 2009-11-12 2011-05-12 Stanley Goldman Human optimized Bacillus anthracis protective antigen
TWI815599B (zh) 2011-04-22 2023-09-11 美商惠氏有限責任公司 與難養芽胞梭菌（Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ）之突變毒素有關之組成物及彼之方法
BR122016023101B1 (pt) 2012-10-21 2022-03-22 Pfizer Inc Polipeptídeo, composição imunogênica que o compreende, bem como célula recombinante derivada de clostridium difficile

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792458A (en) * 1987-10-05 1998-08-11 The United States Of America As Represented By The Department Of Health And Human Services Mutant diphtheria toxin conjugates
US5677274A (en) 1993-02-12 1997-10-14 The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services Anthrax toxin fusion proteins and related methods
US5591631A (en) 1993-02-12 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Anthrax toxin fusion proteins, nucleic acid encoding same
US6455673B1 (en) * 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US5917017A (en) * 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
WO1997023236A1 (fr) 1995-12-13 1997-07-03 President And Fellows Of Harvard College Utilisation de peptides de toxine et/ou de marqueurs d'affinite pour l'introduction de composes dans des cellules
GB9618107D0 (en) * 1996-08-30 1996-10-09 Secr Defence Vaccine production
AU2771099A (en) 1998-02-18 1999-09-06 President And Fellows Of Harvard College Inhibition of toxin translocation
US6426231B1 (en) * 1998-11-18 2002-07-30 The Texas A&M University System Analyte sensing mediated by adapter/carrier molecules
US6413768B1 (en) * 1998-12-02 2002-07-02 University Of Maryland Expression plasmids
US6329156B1 (en) * 1999-03-22 2001-12-11 The Regents Of The University Of California Method for screening inhibitors of the toxicity of Bacillus anthracis

Also Published As

Publication number Publication date
IL152553A0 (en) 2003-05-29
ZA200208835B (en) 2004-02-09
NO20025204D0 (no) 2002-10-30
EP1278764A2 (fr) 2003-01-29
US20020039588A1 (en) 2002-04-04
MXPA02010826A (es) 2006-03-09
US7037503B2 (en) 2006-05-02
AU2001261171A1 (en) 2001-11-12
HUP0301658A2 (hu) 2003-08-28
CN1440419A (zh) 2003-09-03
WO2001082788A9 (fr) 2002-12-19
CA2407443A1 (fr) 2001-11-08
WO2001082788A3 (fr) 2002-07-25
CZ20023662A3 (cs) 2003-04-16
JP2003531841A (ja) 2003-10-28
EP1278764A4 (fr) 2004-05-19
PL365453A1 (en) 2005-01-10
WO2001082788A2 (fr) 2001-11-08
KR20030019366A (ko) 2003-03-06

Similar Documents

Publication Publication Date Title
NO20025204L (no) Forbindelser og fremgangsmåter for behandling og forebygging av bakteriellinfeksjon
NO20021382L (no) Fremgangsmåter og mikroorganismer for fremstilling av panto- forbindelser
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
DK1335678T3 (da) Oralt behandlingssystem
DK1341769T3 (da) Bakterielle gyrase-inhibitorer og anvendelser deraf
DE60139930D1 (de) Desinfizieruns- und desodorierungsverfahren
NO20014314L (no) Blandinger og metoder for behandling av stafylokokkisk infeksjon
HK1074005A1 (en) Compositions and methods for treating or preventing pneumococcal infection
NO20015464L (no) Attenuerte mikroorganismer for behandling av infeksjon
NO20032122L (no) Forbedret behandling
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
NO984949D0 (no) Carbapenem-antibakterielle forbindelser, preparater inneholdende slike forbindelser og behandlingsmetoder
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
DE60140597D1 (de) Vakuumbehandlungsverfahren
DE60125241D1 (de) Wärmebehandlungseinrichtung
NO20022949D0 (no) Attenuerte mikroorganismer for behandling av infeksjon
ID30377A (id) Metoda pengobatan neurodegenerasi
HU0101347D0 (en) Method of treating parasitic infection
EE200200705A (et) Süsteemid ja meetodid limaskesta ravimiseks
FI20000130A0 (fi) Jättenkäsittelymenetelmä ja -laitteisto
NO20022984D0 (no) Forbindelse og fremgangsmåte for behandling av smerte
HU0000207D0 (en) Composition and method for treating sclerotinia infection
AU2003304316A8 (en) Compounds and methods for the treatment and prevention of bacterial infection
AU7367000A (en) Method for treating and preventing bacterial infection
DE60133070D1 (de) Behandlungsgerät und -verfahren

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application